NANOVIRICIDES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
NANOVIRICIDES, INC. (NNVC) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 10.90 million shares for the 12-month period ending 2021-06-30, per its 10-K filed 2021-10-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-10-12
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 11.50M shares, a 39.10% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 10.95M shares, a 68.04% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 10.67M shares, a 176.76% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 10.49M shares, a 172.76% increase year-over-year.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 10.90M shares, a 94.08% increase from fiscal 2020.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 5.62M shares, a 56.45% increase from fiscal 2019.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 3.59M shares, a 10.60% increase from fiscal 2018.
- NANOVIRICIDES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 3.25M shares, a 94.60% decline from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | 11.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | 11.23M shares derived: average of 2 quarters · filed 2021-10-12 | 11.04M shares derived: average of 3 quarters · filed 2021-10-12 | 10.90M shares 10-K · filed 2021-10-12 | ||||
| 2021-03-31 | 10.95M shares 10-Q · filed 2021-05-14 | 10.81M shares derived: average of 2 quarters · filed 2021-05-14 | 10.70M shares 10-Q · filed 2021-05-14 | 10.09M shares derived: average of 4 quarters · filed 2021-10-12 | ||||
| 2020-12-31 | 10.67M shares 10-Q · filed 2021-02-16 | 10.58M shares 10-Q · filed 2021-02-16 | 9.81M shares derived: average of 3 quarters · filed 2021-10-12 | 8.99M shares derived: average of 4 quarters · filed 2021-10-12 | ||||
| 2020-09-30 | 10.49M shares 10-Q · filed 2020-11-16 | 9.38M shares derived: average of 2 quarters · filed 2021-10-12 | 8.43M shares derived: average of 3 quarters · filed 2021-10-12 | 7.28M shares derived: average of 4 quarters · filed 2021-10-12 | ||||
| 2020-06-30 | 8.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | 7.39M shares derived: average of 2 quarters · filed 2021-10-12 | 6.21M shares derived: average of 3 quarters · filed 2021-10-12 | 5.62M shares 10-K · filed 2021-10-12 | ||||
| 2020-03-31 | 6.52M shares 10-Q · filed 2021-05-14 | 5.19M shares derived: average of 2 quarters · filed 2021-05-14 | 4.73M shares 10-Q · filed 2021-05-14 | 4.51M shares derived: average of 4 quarters · filed 2021-10-12 | ||||
| 2019-12-31 | 3.85M shares 10-Q · filed 2021-02-16 | 3.85M shares 10-Q · filed 2021-02-16 | 3.84M shares derived: average of 3 quarters · filed 2021-10-12 | 3.78M shares derived: average of 4 quarters · filed 2021-10-12 | ||||
| 2019-09-30 | 3.85M shares 10-Q · filed 2020-11-16 | 3.84M shares derived: average of 2 quarters · filed 2021-10-12 | 3.76M shares derived: average of 3 quarters · filed 2021-10-12 | 3.69M shares derived: average of 4 quarters · filed 2021-10-12 | ||||
| 2019-06-30 | 3.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | 3.72M shares derived: average of 2 quarters · filed 2021-10-12 | 3.63M shares derived: average of 3 quarters · filed 2021-10-12 | 3.59M shares 10-K · filed 2021-10-12 | 71.80M shares 10-K · filed 2019-08-23 | |||
| 2019-03-31 | 3.60M shares 10-Q · filed 2020-06-22 | 71.96M shares 10-Q · filed 2019-05-15 | 3.53M shares derived: average of 2 quarters · filed 2020-06-22 | 3.51M shares 10-Q · filed 2020-06-22 | 70.16M shares 10-Q · filed 2019-05-15 | -41.80M shares derived: average of 4 quarters · filed 2020-10-13 | ||
| 2018-12-31 | 3.47M shares 10-Q · filed 2020-02-14 | 69.38M shares 10-Q · filed 2019-02-14 | 3.46M shares 10-Q · filed 2020-02-14 | 69.28M shares 10-Q · filed 2019-02-14 | -56.93M shares derived: average of 3 quarters · filed 2020-10-13 | -26.68M shares derived: average of 4 quarters · filed 2020-10-13 | ||
| 2018-09-30 | 3.46M shares 10-Q · filed 2019-11-15 | 69.19M shares 10-Q · filed 2018-11-14 | -87.13M shares derived: average of 2 quarters · filed 2020-10-13 | -36.73M shares derived: average of 3 quarters · filed 2020-10-13 | -11.71M shares derived: average of 4 quarters · filed 2020-10-13 | |||
| 2018-06-30 | -177.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | -56.82M shares derived: average of 2 quarters · filed 2020-10-13 | -16.77M shares derived: average of 3 quarters · filed 2020-10-13 | 3.25M shares 10-K · filed 2020-10-13 | 64.92M shares 10-K · filed 2019-08-23 | |||
| 2018-03-31 | 64.07M shares 10-Q · filed 2019-05-15 | 63.70M shares derived: average of 2 quarters · filed 2019-05-15 | 63.57M shares 10-Q · filed 2019-05-15 | |||||
| 2017-12-31 | 63.34M shares 10-Q · filed 2019-02-14 | 63.32M shares 10-Q · filed 2019-02-14 | ||||||
| 2017-09-30 | 63.31M shares 10-Q · filed 2018-11-14 | |||||||
| 2017-06-30 | 60.10M shares 10-K · filed 2019-08-23 | |||||||
| 2016-09-30 | 58.18M shares 10-Q · filed 2017-11-14 | |||||||
| 2014-09-30 | 55.58M shares 10-Q/A · filed 2015-02-23 | 54.78M shares derived: average of 2 quarters · filed 2015-02-23 | 54.29M shares derived: average of 3 quarters · filed 2015-02-23 | 53.23M shares derived: average of 4 quarters · filed 2015-02-23 | ||||
| 2014-06-30 | 53.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 53.65M shares derived: average of 2 quarters · filed 2015-02-23 | 52.44M shares derived: average of 3 quarters · filed 2015-02-23 | 51.23M shares 10-K · filed 2015-02-23 | ||||
| 2014-03-31 | 53.32M shares 10-Q · filed 2014-05-15 | 51.68M shares derived: average of 2 quarters · filed 2014-05-15 | 50.31M shares 10-Q · filed 2014-05-15 | 49.38M shares derived: average of 4 quarters · filed 2015-02-23 | ||||
| 2013-12-31 | 50.03M shares 10-Q · filed 2014-02-14 | 48.85M shares 10-Q · filed 2014-02-14 | 48.07M shares derived: average of 3 quarters · filed 2015-02-23 | 47.73M shares derived: average of 4 quarters · filed 2015-02-23 | ||||
| 2013-09-30 | 47.67M shares 10-Q/A · filed 2015-02-23 | 47.09M shares derived: average of 2 quarters · filed 2015-02-23 | 46.96M shares derived: average of 3 quarters · filed 2015-02-23 | 46.50M shares derived: average of 4 quarters · filed 2015-02-23 | ||||
| 2013-06-30 | 46.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 46.61M shares derived: average of 2 quarters · filed 2015-02-23 | 46.10M shares derived: average of 3 quarters · filed 2015-02-23 | 45.89M shares 10-K · filed 2015-02-23 | ||||
| 2013-03-31 | 46.70M shares 10-Q · filed 2014-05-15 | 163.45M shares 10-Q/A · filed 2013-05-20 | 45.90M shares derived: average of 2 quarters · filed 2014-05-15 | 45.69M shares 10-Q · filed 2014-05-15 | 159.90M shares 10-Q/A · filed 2013-05-20 | -34.88M shares derived: average of 4 quarters · filed 2015-02-23 | ||
| 2012-12-31 | 45.10M shares 10-Q · filed 2014-02-14 | 157.85M shares 10-Q/A · filed 2013-02-22 | 44.95M shares 10-Q · filed 2014-02-14 | 157.31M shares 10-Q/A · filed 2013-02-22 | -62.07M shares derived: average of 3 quarters · filed 2015-02-23 | -8.66M shares derived: average of 4 quarters · filed 2015-02-23 | ||
| 2012-09-30 | 41.31M shares 10-Q/A · filed 2013-11-18 | 156.78M shares 10-Q · filed 2012-11-19 | -115.66M shares derived: average of 2 quarters · filed 2015-02-23 | -26.58M shares derived: average of 3 quarters · filed 2015-02-23 | 16.93M shares derived: average of 4 quarters · filed 2015-02-23 | |||
| 2012-06-30 | -272.62M shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-23 | -60.53M shares derived: average of 2 quarters · filed 2015-02-23 | 8.80M shares derived: average of 3 quarters · filed 2015-02-23 | 42.76M shares 10-K · filed 2015-02-23 | 149.67M shares 10-K/A · filed 2012-10-26 | |||
| 2012-03-31 | 151.56M shares 10-Q/A · filed 2013-05-20 | 149.51M shares derived: average of 2 quarters · filed 2013-05-20 | 147.89M shares 10-Q/A · filed 2013-05-20 | |||||
| 2011-12-31 | 147.46M shares 10-Q/A · filed 2013-02-22 | 146.00M shares 10-Q/A · filed 2013-02-22 | ||||||
| 2011-09-30 | 144.57M shares 10-Q · filed 2012-11-19 | |||||||
| 2011-06-30 | 139.18M shares 10-K/A · filed 2012-10-26 | |||||||
| 2010-06-30 | 130.50M shares 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |